LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 50 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,487,148 | +54.7% | 3,414,468 | 0.0% | 5.35% | +102.0% |
| Q2 2023 | $8,720,383 | -29.9% | 3,414,468 | +24.3% | 2.65% | -19.9% |
| Q1 2023 | $12,440,580 | -13.3% | 2,746,265 | -20.9% | 3.30% | -13.6% |
| Q4 2022 | $14,345,001 | +31.3% | 3,473,366 | +1.7% | 3.82% | +30.1% |
| Q3 2022 | $10,928,000 | +267.9% | 3,415,148 | +125.4% | 2.94% | +159.1% |
| Q2 2022 | $2,970,000 | -51.6% | 1,515,148 | 0.0% | 1.13% | -56.5% |
| Q1 2022 | $6,136,000 | -62.5% | 1,515,148 | 0.0% | 2.61% | -51.9% |
| Q4 2021 | $16,348,000 | -6.4% | 1,515,148 | 0.0% | 5.43% | +6.4% |
| Q3 2021 | $17,470,000 | +17.4% | 1,515,148 | 0.0% | 5.10% | +47.3% |
| Q2 2021 | $14,879,000 | -32.8% | 1,515,148 | 0.0% | 3.46% | -21.9% |
| Q1 2021 | $22,136,000 | -31.8% | 1,515,148 | 0.0% | 4.43% | -51.5% |
| Q4 2020 | $32,439,000 | +41.1% | 1,515,148 | 0.0% | 9.14% | +11.8% |
| Q3 2020 | $22,985,000 | +18.1% | 1,515,148 | 0.0% | 8.18% | +7.6% |
| Q2 2020 | $19,470,000 | – | 1,515,148 | – | 7.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
| Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
| GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
| DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
| COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
| Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
| Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
| MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |